LAUSR

Concerning the current Refugee crisis in Europe,1 we consider his moment opportune to comment upon the situation of the utochthonous malaria in Greece, focusing our thoughts on this ewly raising concern. As we commented upon in our previous paper,2 malaria emained a rare disease in the EU during the period 2009–2012 ut few notorious cases of autochthonous malaria in Greece t that time, triggered an Action Plan for the Management of alaria (2012–2015) which was introduced in Greece during he spring of 2012 and carried out by Greek Health Authorities HCDCP) in collaboration with the WHO (World Health Organizaion) and the European Center for Disease Prevention and Control ECDC). The aim was to avoid its reintroduction and subsequent xpansion in Greece. Surveillance results were successful on 2014 ith none cases3 reported and, apparently very rapidly, the WHO as recently declared Malaria-free Europe4 area. However, cases of ocal-acquired malaria by Plasmodium vivax have been reported in reece on 2015 and 2016. In the light of these local-acquired transmissions occurred by ector-borne (Anopheles mosquitoes) from other humans who ave been previously infected from a malaria endemic or epidemic rea, the more imported malaria cases (Plasmodium vivax relapse ases with dormant hypnozoites), the more locally-acquired cases re to be expected when imported cases transit areas with conrmed or suspected circulation of the competent vector. Potential